Market

Did You Know?

Diagnostic blood testing accounts for 70% of the information needed to make an accurate patient diagnosis.  But there is no access to these critical tests 50% of the time.

25 primary blood tests represent 80% of all testing volume accounting for more than 2 billion tests per year and over $20 billion in expenditures. There is no single instrument capable of performing the majority of primary tests at Point of Care.


Growing demand for decentralized testing. Healthcare is rapidly decentralizing on a global basis as providers seek to increase efficiencies, improve clinical outcomes and decrease costs. The vast majority of patient care around the world today is provided in medical clinics with low to moderate test volumes.

Lack of access to critical tests. Relying on an external lab for patient test results presents an expensive and time consuming logistical challenge that can be solved in part by performing testing at the patient's side. However, the lack of a comprehensive and affordable solution for blood testing means providers in low and mid-volume care settings have no practical testing solution. This forces physicians to make diagnoses without complete data.

Significant market size. In developing countries, half the world's population is without quality diagnostics. Their growing middle class has the ability to pay for medical care, however, there is limited or no access to diagnostic testing. This is due to the prohibitive cost of traditional lab equipment and the lack of medical technicians required to perform the tests.


Ativa Medical is developing a micro-lab which will incorporate multiple detection methods, and be able to perform many of the commonly ordered blood tests. It will enable critical hematology and chemistry testing to be affordably performed by general healthcare practitioners in all sites of care around the world.

In addition, the ability to conduct a broad range of tests with a single instrument provides an immediate comprehensive diagnostic picture, thereby enabling efficient management of disease and illness states. 

The result? Expedited patient diagnosis, treatment, and disposition.

 





See the Ativa Solution now, or contact us to learn more.



Analyzer and Test Cards
How it works
Features/Benefits
Ativa Leadership
Ativa Partnerships
Ativa News
Terms and Conditions
Privacy
Ativa Medical Corporation
1000 Westgate Drive, Suite 100
St. Paul, Minnesota 55114 612.293.3993 Direct
© Ativa Medical Corporation 2017 All rights Reserved
 
This device has not been evaluated, cleared or approved for use by the FDA, and is not for sale in the US. Safety and effectiveness have not been established.


All statements that address expectations or projections about the future, including statements about product development, market position, and financial results, are forward-looking statements. Forward-looking statements can be identified by words like "expect," "may," "could," "believe," "would," "might," "anticipates," and similar expressions. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. We undertake no obligation to update any forward-looking statements.